Clinical use of probiotics in pediatrics
Abstract
The use of probiotics, which was until recently a part of the alternative medicine context, is nowadays a “medical hit”. Proof that intestinal microflora is an important part of the intestinal immune and non-immune system represents the basic context of probiotics. These are living microorganisms added to food in sufficient amount for improving intestinal flora and favourably influencing health. The most important mechanisms of probiotic activity are synthesis of antimicrobial agents, use of nutrients necessary for growth of pathogenic flora, inhibition of pathogenic bacterial adhesion, toxins and toxin receptors modification, activation of the immune system by increasing immunoglobulin secretion and cytokine production (interleukin-10 and transforming growth factor–TGF), and decreasing the production of cytokines, tumor necrotizing factor–TNF-α, interferon, and others. Numerous studies in paediatrics have been conducted in the last 20 years with the purpose to define the role of probiotics in different diseases– their use in the prevention and treatment of acute and chronic gastrointestinal diseases as well as of other diseases and disorders, such as atopies, respiratory infections, and others. The use of probiotics is generally estimated as safe since the used microorganisms are the same as those found in the digestive system of a healthy person. In paediatrics the most intense research on probiotics has been performed in treating acute gastroenetrocolitis where their positive effect has already been proved. There are only few studies confirming the effect of probiotics in other gastrointestinal diseases although the results are promising. The research was focused on a few probiotic strains only and therefore the results cannot be generalized. The use of probiotics, which was until recently a part of the alternative medicine context, is nowadays a “medical hit”. Proof that intestinal microflora is an important part of the intestinal immune and non-immune system represents the basic context of probiotics. These are living microorganisms added to food in sufficient amount for improving intestinal flora and favourably influencing health. The most important mechanisms of probiotic activity are synthesis of antimicrobial agents, use of nutrients necessary for growth of pathogenic flora, inhibition of pathogenic bacterial adhesion, toxins and toxin receptors modification, activation of the immune system by increasing immunoglobulin secretion and cytokine production (interleukin-10 and transforming growth factor–TGF), and decreasing the production of cytokines, tumor necrotizing factor–TNF-α, interferon, and others. Numerous studies in paediatrics have been conducted in the last 20 years with the purpose to define the role of probiotics in different diseases– their use in the prevention and treatment of acute and chronic gastrointestinal diseases as well as of other diseases and disorders, such as atopies, respiratory infections, and others. The use of probiotics is generally estimated as safe since the used microorganisms are the same as those found in the digestive system of a healthy person. In paediatrics the most intense research on probiotics has been performed in treating acute gastroenetrocolitis where their positive effect has already been proved. There are only few studies confirming the effect of probiotics in other gastrointestinal diseases although the results are promising. The research was focused on a few probiotic strains only and therefore the results cannot be generalized. The use of probiotics, which was until recently a part of the alternative medicine context, is nowadays a “medical hit”. Proof that intestinal microflora is an important part of the intestinal immune and non-immune system represents the basic context of probiotics. These are living microorganisms added to food in sufficient amount for improving intestinal flora and favourably influencing health. The most important mechanisms of probiotic activity are synthesis of antimicrobial agents, use of nutrients necessary for growth of pathogenic flora, inhibition of pathogenic bacterial adhesion, toxins and toxin receptors modification, activation of the immune system by increasing immunoglobulin secretion and cytokine production (interleukin-10 and transforming growth factor–TGF), and decreasing the production of cytokines, tumor necrotizing factor–TNF-α, interferon, and others. Numerous studies in paediatrics have been conductedin the last 20 years with the purpose to define the role of probiotics in different diseases– their use in the prevention and treatment of acute and chronic gastrointestinal diseases as well as of other diseases and disorders, such as atopies, respiratory infections, and others. The use of probiotics is generally estimated as safe since the used microorganisms are the same as those found in the digestive system of a healthy person. In paediatrics the most intense research on probiotics has been performed in treating acute gastroenetrocolitis where their positive effect has already been proved. There are only few studies confirming the effect of probiotics in other gastrointestinal diseases although the results are promising. The research was focused on a few probiotic strains only and therefore the results cannot be generalized. The use of probiotics, which was until recently a part of the alternative medicine context, is nowadays a “medical hit”. Proof that intestinal microflora is an important part of the intestinal immune and non-immune system represents the basic context of probiotics. These are living microorganisms added to food in sufficient amount for improving intestinal flora and favourably influencing health. The most important mechanisms of probiotic activity are synthesis of antimicrobial agents, use of nutrients necessary for growth of pathogenic flora, inhibition of pathogenic bacterial adhesion, toxins and toxin receptors modification, activation of the immune system by increasing immunoglobulin secretion and cytokine production (interleukin-10 and transforming growth factor–TGF), and decreasing the production of cytokines, tumor necrotizing factor–TNF-α, interferon, and others. Numerous studies in paediatrics have been conducted in the last 20 years with the purpose to define the role of probiotics in different diseases– their use in the prevention and treatment of acute and chronic gastrointestinal diseases as well as of other diseases and disorders, such as atopies, respiratory infections, and others. The use of probiotics is generally estimated as safe since the used microorganisms are the same as those found in the digestive system of a healthy person. In paediatrics the most intense research on probiotics has been performed in treating acute gastroenetrocolitis where their positive effect has already been proved. There are only few studies confirming the effect of probiotics in other gastrointestinal diseases although the results are promising. The research was focused on a few probiotic strains only and therefore the results cannot be generalized. The use of probiotics, which was until recently a part of the alternative medicine context, is nowadays a “medical hit”. Proof that intestinal microflora is an important part of the intestinal immune and non-immune system represents the basic context of probiotics. These are living microorganisms added to food in sufficient amount for improving intestinal flora and favourably influencing health. The most important mechanisms of probiotic activity are synthesis of antimicrobial agents, use of nutrients necessary for growth of pathogenic flora, inhibition of pathogenic bacterial adhesion, toxins and toxin receptors modification, activation of the immune system by increasing immunoglobulin secretion and cytokine production (interleukin-10 and transforming growth factor–TGF), and decreasing the production of cytokines, tumor necrotizing factor–TNF-α, interferon, and others. Numerous studies in paediatrics have been conducted in the last 20 years with the purpose to define the role of probiotics in different diseases– their use in the prevention and treatment of acute and chronic gastrointestinal diseases as well as of other diseases and disorders, such as atopies, respiratory infections, and others. The use of probiotics is generally estimated as safe since the used microorganisms are the same as those found in the digestive system of a healthy person. In paediatrics the most intense research on probiotics has been performed in treating acute gastroenetrocolitis where their positive effect has already been proved. There are only few studies confirming the effect of probiotics in other gastrointestinal diseases although the results are promising. The research was focused on a few probiotic strains only and therefore the results cannot be generalized.The purpose of the article is to present the current state of probiotic use and their effectiveness in gastrointestinal and certain non-gastrointestinal disorders in childhood.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.